<SEC-DOCUMENT>0001019056-24-000080-index.html : 20240214 <SEC-HEADER>0001019056-24-000080.hdr.sgml : 20240214 <ACCEPTANCE-DATETIME>20240214170458 ACCESSION NUMBER: 0001019056-24-000080 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 GROUP MEMBERS: A. GLENN HELMERS GROUP MEMBERS: CONDAGUA, LLC GROUP MEMBERS: JOHN B. HELMERS GROUP MEMBERS: LONG FOCUS CAPITAL MANAGEMENT, LLC GROUP MEMBERS: LONG FOCUS CAPITAL MASTER, LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC CENTRAL INDEX KEY: 0001621227 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88833 FILM NUMBER: 24640257 BUSINESS ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX BUSINESS PHONE: 44 1235 430000 MAIL ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX FORMER COMPANY: FORMER CONFORMED NAME: Adaptimmune Ltd DATE OF NAME CHANGE: 20141001 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Long Focus Capital Management, LLC CENTRAL INDEX KEY: 0001602716 ORGANIZATION NAME: IRS NUMBER: 462772035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 207 CALLE DEL PARQUE STREET 2: A&M TOWER 8TH FLOOR CITY: SAN JUAN STATE: PR ZIP: 00912 BUSINESS PHONE: 864-990-3233 MAIL ADDRESS: STREET 1: 207 CALLE DEL PARQUE STREET 2: A&M TOWER 8TH FLOOR CITY: SAN JUAN STATE: PR ZIP: 00912 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>adaptimmune_13ga1.htm <DESCRIPTION>SC 13G/A <TEXT> Document 1 - file: adaptimmune_13ga1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>ex_1.htm <DESCRIPTION>EXHIBIT 1 <TEXT> Document 2 - file: ex_1.htm
</DOCUMENT> </SEC-DOCUMENT>